New therapeutic options in the management of COPD – focus on roflumilast

References

• The GOLD Workshop Report (Updated 2008): Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease www.goldcopd.com.
   Google Scholar
• BurgePSCalverleyPMJonesPWSpencerSAndersonJAMaslenTKRandomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ200320724512971303
   Web of Science ®Google Scholar
• CalverleyPMBoonsawatWCsekeZZhongNPetersonSOlssonHMaintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur Respir J200322691291914680078
   PubMed Web of Science ®Google Scholar
• MacneeWPathogenesis of chronic obstructive pulmonary diseaseProc Am Thorac Soc200524258266 discussion 290–251.16267346
   PubMedGoogle Scholar
• CosioMGMajoJCosioMGInflammation of the airways and lung parenchyma in COPD: role of T cellsChest20021215 Suppl160S165S12010846
   PubMed Web of Science ®Google Scholar
• MajoJGhezzoHCosioMGLymphocyte population and apoptosis in the lungs of smokers and their relation to emphysemaEur Respir J200117594695311488331
   PubMed Web of Science ®Google Scholar
• RussellREThorleyACulpittSVAlveolar macrophage-mediated elastolysis: roles of matrix metalloproteinases, cysteine, and serine proteasesAm J Physiol Lung Cell Mol Physiol20022834L867L87312225964
   PubMed Web of Science ®Google Scholar
• StockleyRANeutrophils and the pathogenesis of COPDChest20021215 Suppl151S155S12010844
   PubMed Web of Science ®Google Scholar
• Boswell-SmithVSpinaDPDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilastInt J Chron Obstruct Pulmon Dis20072212112918044684
   PubMedGoogle Scholar
• TorphyTJPhosphodiesterase isozymes: molecular targets for novel antiasthma agentsAm J Respir Crit Care Med199815723513709476844
   PubMed Web of Science ®Google Scholar
• BannerKHPageCPTheophylline and selective phosphodiesterase inhibitors as anti-inflammatory drugs in the treatment of bronchial asthmaEur Respir J19958699610007589387
   PubMed Web of Science ®Google Scholar
• BarnesPJTheophylline in chronic obstructive pulmonary disease: new horizonsProc Am Thorac Soc200524334339 discussion 340–331.16267358
   PubMedGoogle Scholar
• BarnesPJTheophylline: new perspectives for an old drugAm J Respir Crit Care Med2003167681381812623857
   PubMed Web of Science ®Google Scholar
• RabeKFMagnussenHDentGTheophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxantsEur Respir J1995846376427664866
   PubMed Web of Science ®Google Scholar
• RabeKFTenorHDentGSchudtCLiebigSMagnussenHPhosphodiesterase isozymes modulating inherent tone in human airways: identification and characterizationAm J Physiol19932645 Pt 1L458L4647684572
   PubMed Web of Science ®Google Scholar
• McKaySEHowieCAThomsonAHWhitingBAddisGJValue of theophylline treatment in patients handicapped by chronic obstructive lung diseaseThorax19934832272328497820
   PubMed Web of Science ®Google Scholar
• MurcianoDAuclairMHParienteRAubierMA randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary diseaseN Engl J Med198932023152115252498658
   PubMed Web of Science ®Google Scholar
• CulpittSVDe MatosCRussellREDonnellyLERogersDFBarnesPJEffect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2002165101371137612016098
   PubMed Web of Science ®Google Scholar
• KobayashiMNasuharaYBetsuyakuTEffect of low-dose theophylline on airway inflammation in COPDRespirology20049224925415182277
   PubMed Web of Science ®Google Scholar
• JaffarZHSullivanPPageCCostelloJLow-dose theophylline modulates T-lymphocyte activation in allergen-challenged asthmaticsEur Respir J1996934564628730004
   PubMed Web of Science ®Google Scholar
• DjukanovicRFinnertyJPLeeCWilsonSMaddenJHolgateSTThe effects of theophylline on mucosal inflammation in asthmatic airways: biopsy resultsEur Respir J1995858318337656958
   PubMed Web of Science ®Google Scholar
• FinnertyJPLeeCWilsonSMaddenJDjukanovicRHolgateSTEffects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo-controlled parallel group studyEur Respir J199698167216778866593
   PubMed Web of Science ®Google Scholar
• IiboshiHAshitaniJIKatohSLong-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary diseasePulm Pharmacol Ther2005
   Google Scholar
• CortijoJBouJBeletaJInvestigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchusBr J Pharmacol199310825625688383567
   PubMed Web of Science ®Google Scholar
• HatzelmannASchudtCAnti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitroJ Pharmacol Exp Ther2001297126727911259554
   PubMed Web of Science ®Google Scholar
• European Medicines Agency Daxas: EPAR – Product Information2010
   Google Scholar
• WollinLBundschuhDSWohlsenAMarxDBeumeRInhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitorsPulm Pharmacol Ther200619534335216257550
   PubMed Web of Science ®Google Scholar
• WollinLMarxDWohlsenABeumeRRoflumilast inhibition of pulmonary leukotriene production and bronchoconstriction in ovalbumin-sensitized and -challenged Guinea pigsJ Asthma2005421087387816393727
   PubMed Web of Science ®Google Scholar
• KumarRKHerbertCThomasPSInhibition of inflammation and remodeling by roflumilast and dexamethasone in murine chronic asthmaJ Pharmacol Exp Ther2003307134935512954795
   PubMed Web of Science ®Google Scholar
• SabatiniFPetecchiaLBoeroSA phosphodiesterase 4 inhibitor, roflumilast N-oxide, inhibits human lung fibroblast functions in vitroPulm Pharmacol Ther23428329120226872
   PubMed Web of Science ®Google Scholar
• FitzgeraldMSpicerDMcaulayAEWollinLBeumeRRoflumilast but not methylprednisolone inhibited cigarette smoke-induced pulmonary inflammation in guinea pigsEur Respir J Suppl2006663s 2010P3850
   Google Scholar
• HardakerEFreemanMSDaleNRazaFMokJBannerKHCharacterisation of a model that mimicks aspects of the hyper-inflammatory response observed during an acute exacerbation of COPDAm J Respir Crit Care Med2009179A5351
   Google Scholar
• HatzelmannAMorcilloEJLungarellaGThe preclinical pharmacology of roflumilast – a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary diseasePulm Pharmacol Ther23423525620381629
   PubMed Web of Science ®Google Scholar
• MartoranaPABeumeRLucattelliMWollinLLungarellaGRoflumilast fully prevents emphysema in mice chronically exposed to cigarette smokeAm J Respir Crit Care Med2005172784885315961691
   PubMed Web of Science ®Google Scholar
• MartoranaPALunghiBLucattelliMDe CuntoGBeumeRLungarellaGEffect of roflumilast on inflammatory cells in the lungs of cigarette smoke-exposed miceBMC Pulm Med200881718755021
   PubMedGoogle Scholar
• MataMSarriaBBuenestadoACortijoJCerdaMMorcilloEJPhosphodiesterase 4 inhibition decreases MUC5AC expression induced by epidermal growth factor in human airway epithelial cellsThorax200560214415215681504
   PubMed Web of Science ®Google Scholar
• GrootendorstDCGauwSAVerhooselRMReduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPDThorax200762121081108717573446
   PubMed Web of Science ®Google Scholar
• RabeKFBatemanEDO’DonnellDWitteSBredenbrokerDBethkeTDRoflumilast – an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trialLancet2005366948556357116099292
   PubMed Web of Science ®Google Scholar
• Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease Ratio-Study. (BY217/M2-112).
   Google Scholar
• CalverleyPMSanchez-TorilFMcIvorATeichmannPBredenbroekerDFabbriLMEffect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2007176215416117463412
   PubMed Web of Science ®Google Scholar
• MartinezFCalverleyPMAGoehringUMRennardSIDefining patient populations in COPD: experience with roflumilast2010
   Google Scholar
• OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111).
   Google Scholar
• FabbriLMCalverleyPMIzquierdo-AlonsoJLRoflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trialsLancet2009374969169570319716961
   PubMed Web of Science ®Google Scholar
• CalverleyPMRabeKFGoehringUMKristiansenSFabbriLMMartinezFJRoflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trialsLancet2009374969168569419716960
   PubMed Web of Science ®Google Scholar
• Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124).
   Google Scholar
• Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The HERMES Study (BY217/M2-125).
   Google Scholar
• CarpenterDOBriggsDBKnoxAPStromingerNExcitation of area postrema neurons by transmitters, peptides, and cyclic nucleotidesJ Neurophysiol19885923583692895167
   PubMed Web of Science ®Google Scholar
• HouslayMDAdamsDRPDE4 cAMP phosphodiesterases: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalizationBiochem J.2003370Pt 111812444918
   PubMed Web of Science ®Google Scholar
• LamontagneSMeadowsELukPLocalization of phosphodiesterase-4 isoforms in the medulla and nodose ganglion of the squirrel monkeyBrain Res20019201–2849611716814
   PubMed Web of Science ®Google Scholar
• RobichaudAStamatiouPBJinSLDeletion of phosphodiesterase 4D in mice shortens alpha(2)-adrenoceptor-mediated anesthesia, a behavioral correlate of emesisJ Clin Invest200211071045105212370283
   PubMed Web of Science ®Google Scholar
• LehnartSEWehrensXhReikenSPhosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmiasCell20051231253516213210
   PubMed Web of Science ®Google Scholar
• McCluskieKKleinULinneversCPhosphodiesterase type 4 inhibitors cause proinflammatory effects in vivoJ Pharmacol Exp Ther2006319146847616861399
   PubMed Web of Science ®Google Scholar
• JinSLContiMInduction of the cyclic nucleotide phosphodiesterase PDE4B is essential for LPS-activated TNF-alpha responsesProc Natl Acad Sci U S A200299117628763312032334
   PubMed Web of Science ®Google Scholar
• JinSLLanLZoudilovaMContiMSpecific role of phosphodiesterase 4B in lipopolysaccharide-induced signaling in mouse macrophagesJ Immunol200517531523153116034090
   PubMed Web of Science ®Google Scholar
• JinSLGoyaSNakaeSPhosphodiesterase 4B is essential for T(H)2-cell function and development of airway hyperresponsiveness in allergic asthmaJ Allergy Clin Immunol126612521259 e121221047676
   PubMed Web of Science ®Google Scholar
• HamblinJNAngellTDBallantineSPPyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitorsBioorg Med Chem Lett200818144237424118539455
   PubMed Web of Science ®Google Scholar
• ChapmanRWHouseAJonesHEffect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway ratsEur J Pharmacol20075712–321522117610865
   PubMed Web of Science ®Google Scholar
• ChapmanRWHouseARichardJPharmacology of a potent and selective inhibitor of PDE4 for inhaled administrationEur J Pharmacol6432–327428120621091
   PubMed Web of Science ®Google Scholar